Sign in
Active, not recruitingNo phase

D615L vs Zeiss 839MP: Visual Quality

Key facts

Who runs it
Shanghai 10th People's Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
90 people enrolled
Started
1 Apr 2025
Expected to end
31 Dec 2026
Type of study
Observational, 2 groups
Treatments tested
  • Trifocal IOL
Record updated
6 May 2026

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • diagnosed age-related cataract
  • preoperative corneal astigmatism <1.0 D
  • endothelial cell count >2000/mm²
  • signed informed consent and ability to complete 6-month follow-up

Who cannot take part

  • prior corneal refractive, glaucoma or vitreoretinal surgery
  • uncontrolled systemic disease such as diabetes or autoimmune disorders
  • intraoperative posterior capsule rupture, zonular dehiscence or vitreous loss
  • corneal pathology, macular edema or optic neuropathy affecting visual assessment
  • active ocular inflammation, glaucoma, maculopathy or diabetic retinopathy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this prospective cohort study is to compare visual quality after cataract surgery in patients implanted with a new domestic trifocal intraocular lens (D615L) versus the Zeiss AT LISA tri 839MP. The main question it aims to answer is: Is the uncorrected distance, intermediate, and near visual acuity achieved with D615L non-inferior or superior to that achieved with the Zeiss 839MP? Participants diagnosed with age-related cataract will undergo phacoemulsification and receive one of the two intraocular lenses. They will attend follow-up visits where uncorrected visual acuity, defocus curves, and the VF-14 questionnaire will be assessed over a follow-up period of at least 6 months.

The 2 groups in the trial

  • D615L

    implanted D615L IOL

    Treatment: Trifocal IOL

  • 839MP

    implanted 839MP IOL

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Comparative Study on Postoperative Visual Quality: New Domestic Trifocal IOL (D615L) Versus Zeiss AT LISA Tri 839MP
Record updated
6 May 2026